Literature DB >> 23060660

Postmarket surveillance for medical devices: America's new strategy.

Sharon-Lise T Normand, Laura Hatfield, Joseph Drozda, Frederic S Resnic.   

Abstract

Mesh:

Year:  2012        PMID: 23060660     DOI: 10.1136/bmj.e6848

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  13 in total

Review 1.  Approval of high-risk medical devices in the US: implications for clinical cardiology.

Authors:  Benjamin N Rome; Daniel B Kramer; Aaron S Kesselheim
Journal:  Curr Cardiol Rep       Date:  2014       Impact factor: 2.931

2.  Constructing the informatics and information technology foundations of a medical device evaluation system: a report from the FDA unique device identifier demonstration.

Authors:  Joseph P Drozda; James Roach; Thomas Forsyth; Paul Helmering; Benjamin Dummitt; James E Tcheng
Journal:  J Am Med Inform Assoc       Date:  2018-02-01       Impact factor: 4.497

3.  Medical device postapproval safety monitoring: where does the United States stand?

Authors:  Prashant V Rajan; Daniel B Kramer; Aaron S Kesselheim
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-01-06

4.  Registry-Based Prospective, Active Surveillance of Medical-Device Safety.

Authors:  Frederic S Resnic; Arjun Majithia; Danica Marinac-Dabic; Susan Robbins; Henry Ssemaganda; Kathleen Hewitt; Angelo Ponirakis; Nilsa Loyo-Berrios; Issam Moussa; Joseph Drozda; Sharon-Lise Normand; Michael E Matheny
Journal:  N Engl J Med       Date:  2017-01-25       Impact factor: 91.245

5.  Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures.

Authors:  Frederic S Resnic; Arjun Majithia; Sanket S Dhruva; Henry Ssemaganda; Susan Robbins; Danica Marinac-Dabic; Kathleen Hewitt; Lucila Ohno-Machado; Matthew R Reynolds; Michael E Matheny
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-04-14

6.  The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillance.

Authors:  Amit Kumar; Michael E Matheny; Kalon K L Ho; Robert W Yeh; Thomas C Piemonte; Howard Waldman; Pinak B Shah; Richard Cope; Sharon-Lise T Normand; Sharon Donnelly; Susan Robbins; Frederic S Resnic
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-12-09

7.  Assessing the cost burden of United States FDA-mandated post-approval studies for medical devices.

Authors:  Neil J Wimmer; Susan Robbins; Henry Ssemaganda; Erin Yang; Sharon-Lise Normand; Michael E Matheny; Naomi Herz; Josh Rising; Frederic S Resnic
Journal:  J Health Care Finance       Date:  2016

8.  Pivotal clinical trials of novel ophthalmic drugs and medical devices: retrospective observational study, 2002-2012.

Authors:  Jenny Hwang; Thomas J Hwang; Joseph B Ciolino
Journal:  BMJ Open       Date:  2015-06-04       Impact factor: 2.692

9.  Advances in the Use of Real-World Evidence for Medical Devices: An Update From the National Evaluation System for Health Technology.

Authors:  Rachael L Fleurence; Jeffrey Shuren
Journal:  Clin Pharmacol Ther       Date:  2019-03-19       Impact factor: 6.875

Review 10.  Regulatory approval of new medical devices: cross sectional study.

Authors:  Hani J Marcus; Christopher J Payne; Archie Hughes-Hallett; Adam P Marcus; Guang-Zhong Yang; Ara Darzi; Dipankar Nandi
Journal:  BMJ       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.